Nutex Health Inc. (NUTX) Stock Analysis
Healthcare · Medical Care Facilities · NasdaqCM
Nutex Health Inc. (NUTX) posted $875.26M in revenue for fiscal 2025 (up 82.4% year over year), at a 8.1% net margin, and has compounded revenue about 26.1%/yr over five years, per its SEC filings.
Data last refreshed September 3, 2026 from SEC filings · how we compute this
The analyst's take on Nutex Health Inc.
Nutex Health Inc. has grown revenue from $0 to $875.26M over the last 10 fiscal years, compounding about 26.1% a year. The most recent year was up 82.4%, so growth is actually accelerating.
Net margin sits at 8.1%, down 2.8 points year over year on a 50.8% gross margin. It carries about $43.25M of total debt.
At today's valuation the market is pricing in roughly -16.2% annual free-cash-flow growth — versus the 57.3% it actually delivered over the last five years, so the price is arguably undemanding against what it has already proven. It clears 5 of 8 deterministic health checks. The one thing worth a second look in the filings is share count rising (dilution).
Synthesised from Nutex Health Inc.'s SEC filings — descriptive, not advice. Ask the analyst your own question →
See a claim about Nutex Health Inc.? Check it against the filing
Open the full tool →Paste a headline number you saw about NUTX — a press-release figure, a tweet, another tool’s number — and see the filed SEC number side-by-side with its source. Free, no account.
Nutex Health Inc. revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $23,166 | $1.37M | $1.37M | $274.03M | $331.53M | $219.29M | $247.65M | $479.95M | $875.26M |
| Gross profit | — | $-7,315 | $859,356 | $535,976 | $157.61M | $179.28M | $15.42M | $34.77M | $196.26M | $444.28M |
| Net income | $-7.43M | $582,062 | $-950,129 | $-7.12M | $105.97M | $132.59M | $-424.78M | $-45.79M | $52.10M | $70.79M |
| Net margin | — | 2512.6% | -69.5% | -520.8% | 38.7% | 40.0% | -193.7% | -18.5% | 10.9% | 8.1% |
Source: Nutex Health Inc. SEC filings (10-K). 16 years of history available in the interactive view.
Nutex Health Inc. financial health: 5 of 8 checks passed
- ✓Revenue CAGR over 15 yrs (58.5%/yr)
- ✗Profitable every year (last 5)
- ✗Net margin above 10% (8.1%)
- ✓More cash than total debt (cash 185.6M vs debt 57.3M)
- ✓Positive operating cash flow (last 5 yrs)
- ✓Free cash flow positive (latest yr) (245.6M)
- ✗Share count falling over 5 yrs (buybacks) (5.3M → 7.1M shares)
- ✓Pays a dividend (4 consecutive yrs in our data)
Checks computed deterministically from filed annual statements — no AI judgement.
Nutex Health Inc.: 1 potential red flag in the filings
Patterns in the filed statements worth a second look — computed and cited, not AI guesswork, and not a signal to sell. The kind of thing that hides in a 10-K.
- Share count rising (dilution)Shares outstanding grew 79.3% over 4 years (4M → 7.1M) — existing holders' stakes are being diluted.
What growth is priced into NUTX stock?
At today's market cap of $953.82M, Nutex Health Inc. is priced for free-cash-flow growth of about -16.2% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $245.60M from the FY ending 2025-12-31). For comparison, free cash flow actually grew 57.3%/yr over the last five fiscal years and revenue 26.1%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 16 years of Nutex Health Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a $24.99/month plan to track NUTX in your portfolio →
Nutex Health Inc. financial history
About Nutex Health Inc.
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatient pharmacies. The PHM segment provides management, administrative, and other support services to its affiliated hospitals and physician groups by establishing and operating provider networks, such as independent physician associations (IPAs); and a cloud-based technology platform for IPAs. The Real Estate segment owns and leases land and hospital buildings. Nutex Health Inc. was founded in 2011 and is headquartered in Houston, Texas.
Nutex Health Inc. — frequently asked questions
What is Nutex Health Inc.'s revenue?
Nutex Health Inc. (NUTX) reported revenue of $875.26M for fiscal year 2025, up 82.4% from the prior year, according to its SEC filings.
Is Nutex Health Inc. profitable?
Yes. NUTX earned net income of $70.79M in fiscal 2025, a net margin of 8.1%.
What is NUTX's P/E ratio?
Nutex Health Inc. trades at a price-to-earnings ratio of about 10.1 based on the latest data in our nightly-refreshed cache.
How fast is Nutex Health Inc. growing?
NUTX's revenue grew at roughly 26.1% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
Does Nutex Health Inc. pay a dividend?
Yes, NUTX pays a dividend.
How much debt does Nutex Health Inc. have?
As of fiscal year 2025, NUTX carried roughly $43.25M in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Nutex Health Inc.'s gross margin?
NUTX's gross margin was 50.8% in fiscal 2025 — gross profit of $444.28M on revenue of $875.26M.
What is Nutex Health Inc.'s market cap?
Nutex Health Inc. (NUTX) has a market capitalization of about $953.82M, based on the latest data in our nightly-refreshed cache.
When does Nutex Health Inc.'s fiscal year end?
NUTX's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into NUTX stock?
At today's market cap of $953.82M, Nutex Health Inc. is priced for free-cash-flow growth of about -16.2% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $245.60M from the FY ending 2025-12-31). For comparison, free cash flow actually grew 57.3%/yr over the last five fiscal years and revenue 26.1%/yr, computed from its SEC filings.
Where does this data come from?
All figures are computed from Nutex Health Inc.'s official SEC filings (10-K and 10-Q), covering 16 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.